SIGN makes sense of evidence
SIGN 155: Pharmacological management of migraine - update
We’ve updated SIGN 155: Pharmacological management of migraine, to include advice on the use of oral calcitonin gene-related peptide receptor antagonists.
View the guideline:
SIGN 155: Pharmacological management of migraine
SIGN guideline: Management of chronic pain (part 2)
Part 2 of the draft SIGN guideline on the management of chronic pain is available for consultation. Click here for further information.
